Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
152.11
Dollar change
0.00
Percentage change
0.00
%
Index- P/E2287.37 EPS (ttm)0.07 Insider Own6.16% Shs Outstand93.73M Perf Week0.25%
Market Cap14.38B Forward P/E12.25 EPS next Y12.42 Insider Trans-1.33% Shs Float88.70M Perf Month25.32%
Income16.90M PEG- EPS next Q-0.13 Inst Own87.27% Short Float10.77% Perf Quarter22.23%
Sales1.40B P/S10.25 EPS this Y171.77% Inst Trans6.35% Short Ratio5.19 Perf Half Y27.62%
Book/sh10.17 P/B14.95 EPS next Y198.34% ROA0.54% Short Interest9.56M Perf Year40.86%
Cash/sh14.71 P/C10.34 EPS next 5Y- ROE2.02% 52W Range55.25 - 173.25 Perf YTD57.74%
Dividend Est.- P/FCF- EPS past 5Y-1.21% ROI0.76% 52W High-12.20% Beta0.88
Dividend TTM- Quick Ratio3.44 Sales past 5Y32.89% Gross Margin85.20% 52W Low175.31% ATR (14)5.93
Dividend Ex-Date- Current Ratio4.05 EPS Y/Y TTM101.12% Oper. Margin-6.76% RSI (14)60.95 Volatility2.55% 3.81%
Employees1314 Debt/Eq1.44 Sales Y/Y TTM43.83% Profit Margin1.20% Recom1.43 Target Price197.20
Option/ShortYes / Yes LT Debt/Eq1.33 EPS Q/Q106.22% Payout- Rel Volume0.65 Prev Close152.11
Sales Surprise8.94% EPS Surprise2768.22% Sales Q/Q63.10% EarningsMay 01 AMC Avg Volume1.84M Price152.11
SMA204.90% SMA5013.15% SMA20029.84% Trades Volume1,189,997 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jun-26-24Downgrade Citigroup Buy → Neutral $172 → $176
May-31-24Initiated Piper Sandler Overweight $157
May-28-24Downgrade RBC Capital Mkts Outperform → Sector Perform $157 → $142
May-14-24Upgrade Oppenheimer Perform → Outperform $180
Jan-31-24Initiated BMO Capital Markets Outperform $170
Dec-13-23Resumed Citigroup Buy $113
Dec-12-23Initiated Deutsche Bank Buy $109
Nov-21-23Initiated Wedbush Outperform $224
Oct-31-23Downgrade Oppenheimer Outperform → Perform
Oct-31-23Downgrade Cantor Fitzgerald Overweight → Neutral $166 → $40
Jul-08-24 12:04PM
Jul-06-24 08:00AM
Jul-04-24 06:35AM
Jul-03-24 10:05AM
Jun-28-24 06:30PM
10:06AM Loading…
Jun-26-24 10:06AM
03:45AM
Jun-24-24 02:55PM
03:49AM
Jun-21-24 05:25PM
05:05PM
04:28PM
04:23PM
02:39PM
01:53PM
01:00PM Loading…
01:00PM
12:58PM
12:48PM
12:29PM
12:14PM
11:24AM
11:09AM
11:00AM
10:42AM
09:32AM
09:31AM
09:14AM
08:42AM
07:52AM
07:34AM
06:40AM Loading…
06:40AM
Jun-20-24 05:02PM
02:13PM
01:22PM
Jun-13-24 04:04PM
01:07PM
07:00AM
Jun-06-24 07:00AM
May-31-24 05:45PM
11:31AM
May-29-24 05:48PM
08:28AM
May-28-24 10:52PM
May-24-24 11:57AM
May-23-24 07:10AM
May-17-24 08:05AM
May-14-24 07:30AM
May-04-24 12:00PM
May-03-24 10:07AM
May-02-24 03:42PM
11:30AM
11:13AM
11:08AM
07:52AM
06:01AM
03:32AM
May-01-24 08:55PM
07:30PM
07:30PM
05:20PM
05:06PM
04:19PM
04:05PM
09:15AM
Apr-30-24 06:38PM
09:28AM
Apr-29-24 03:20PM
Apr-24-24 08:30AM
Apr-13-24 09:39PM
Apr-08-24 04:13PM
Apr-06-24 08:45AM
Apr-02-24 07:04AM
Mar-29-24 04:00PM
11:30AM
Mar-26-24 07:49AM
Mar-25-24 10:00AM
Mar-17-24 08:50AM
Mar-14-24 03:53PM
Mar-13-24 08:00AM
Mar-12-24 01:18AM
Mar-11-24 09:03AM
Mar-06-24 11:54PM
Mar-04-24 09:47AM
08:30AM
Mar-02-24 12:05AM
Feb-29-24 06:16PM
12:35PM
10:52AM
09:00AM
12:00AM
Feb-28-24 06:00PM
04:23PM
04:05PM
07:15AM
Feb-27-24 08:48AM
Feb-21-24 11:24AM
08:30AM
Feb-20-24 10:00AM
Feb-19-24 03:26AM
Feb-16-24 11:23AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEHRENS M KATHLEENDirectorJul 03 '24Option Exercise13.9015,000208,500191,839Jul 08 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Option Exercise62.7723,5001,475,09556,086Jun 25 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Sale161.6138,9576,296,02917,129Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 25 '24Sale163.233,898636,27117,363Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 24 '24Sale163.087,8591,281,62121,261Jun 25 08:00 PM
Murray DallanChief Customer OfficerMay 02 '24Sale140.003,635508,90018,125May 06 08:09 PM
Boor Kathryn JeanDirectorMar 11 '24Sale122.9376193,5507,516Mar 11 08:00 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Option Exercise13.9015,000208,50037,840Mar 11 08:02 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Sale123.2515,0001,848,79522,840Mar 11 08:02 PM
Mayo StephenDirectorMar 05 '24Sale122.963,135385,4806,621Mar 06 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01 '24Sale128.842,000257,67626,836Mar 05 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 01 '24Sale125.342,000250,68031,827Mar 05 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 01 '24Sale128.301,200153,96039,114Mar 05 08:00 PM
BEHRENS M KATHLEENDirectorNov 03 '23Option Exercise29.0315,000435,450174,993Nov 06 08:00 AM
Barry RichardDirectorNov 03 '23Buy78.8150,0003,940,500140,000Nov 06 08:00 AM
INGRAM DOUGLAS SPresident & CEONov 03 '23Buy79.3625,2252,001,800390,307Nov 06 08:00 AM
Chambers Michael AndrewDirectorAug 14 '23Buy109.479,9791,092,429246,996Aug 15 08:00 AM
Chambers Michael AndrewDirectorAug 11 '23Buy108.0523,6862,559,272237,017Aug 14 08:00 AM
Chambers Michael AndrewDirectorAug 10 '23Buy106.1534,8673,701,067213,331Aug 11 07:40 AM
Wigzell Hans Lennart RudolfDirectorAug 04 '23Option Exercise29.0315,000435,45035,994Aug 08 08:00 PM
Wigzell Hans Lennart RudolfDirectorAug 04 '23Sale106.7215,0001,600,80020,994Aug 08 08:00 PM